Wissenschaftliche Publikationen Suche Suche Autor/in Forschungsgruppe Veröffentlichungsdatum Suchen Sortieren nach RelevanceFrom A-ZAuthored onDate/Time RangeRelease date Reihenfolge AufsteigendAbsteigend Daniel, Peter Prof. Dr. (1) Daumke, Oliver Prof. Dr. (5) Dechend, Ralf Priv. Doz. (1) Fälber, Katja Dr. (1) Geisberger, Sabrina Yasmin Dr. (1) Haucke, Volker Professor (1) Hinz, Michael Dr. (1) Kammertöns, Thomas Dr. (4) Leisegang, Matthias Prof. Dr. rer. nat. (2) Müller, Dominik Prof. Dr. (1) Müller, Gerd Dr. (1) Pezzutto, Antonio Prof. Dr. (3) Schlegel, Jeanette (1) Siffrin, Volker (1) Uckert, Wolfgang Prof. Dr. (2) Willimsky, Gerald Dr. (3) Yilmaz, Zekiye Buket Dr. (1) (-) Blankenstein, Thomas Prof. Dr. (11) (-) Höpken, Uta Elisabeth PD Dr. (1) (-) Kopp, Joachim Dr. (1) Biologie maligner Lymphome (6) Mikroumgebung als Regulator bei Autoimmunität und Krebs (3) (-) Molekulare Immunologie und Gentherapie (11) (-) Strukturbiologie Membran-assoziierter Prozesse (1) Systembiologie von Gen-regulatorischen Elementen (1) 1992 (4) 1993 (7) 1994 (5) 1995 (8) 1996 (6) 1997 (9) 1998 (9) 1999 (2) (-) 2000 (8) 2001 (5) 2002 (5) 2003 (9) 2004 (8) 2005 (10) 2006 (1) 2007 (5) 2008 (5) 2009 (2) 2010 (7) 2011 (5) 2012 (6) 2014 (3) (-) 2015 (4) 2016 (4) 2017 (6) 2018 (5) 2019 (7) 2021 (4) 2022 (6) 2023 (7) 2024 (1) 12 Ergebnisse: Active Filter: Blankenstein, Thomas Prof. Dr.Höpken, Uta Elisabeth PD Dr.Kopp, Joachim Dr.Molekulare Immunologie und Gentherapie Strukturbiologie Membran-assoziierter Prozesse20002015 Sortieren: Treffgenauigkeit Neueste nach älteste Älteste nach neueste 01. Januar 2000 / Hum Gene Ther Efficient gene transfer into primary human CD8+ T lymphocytes by MuLV-10A1 retrovirus pseudotype W. Uckert C. Becker M. Gladow D. Klein T. Kammertoens L. Pedersen T. Blankenstein 01. Juni 2000 / Immunity CD4+ T cell-mediated tumor rejection involves inhibition of angiogenesis that is dependent on IFNgamma receptor expression by nonhematopoietic cells Z.H. Qin T. Blankenstein 01. Mai 2000 / Bone Marrow Transplant Bcr/abl+ autologous dendritic cells for vaccination in chronic myeloid leukemia J. Westermann J. Kopp I. Koerner G. Richter Z. Qin T. Blankenstein B. Doerken A. Pezzutto 01. Mai 2000 / Bone Marrow Transplant Allogeneic vaccination for renal cell carcinoma: development and monitoring H. Pohla B. Frankenberger B. Stadlbauer R. Oberneder A. Hofstetter G. Willimsky A. Pezzutto B. Doerken T. Blankenstein D.J. Schendel 01. Oktober 2000 / Tissue Antigens Coordinate downregulation of multiple MHC class I antigen processing genes in chemical-induced murine tumor cell lines of distinct origin B. Seliger U. Wollscheid F. Momburg T. Blankenstein C. Huber 01. Dezember 2000 / Gene Ther Expression of B7.1 (CD80) in a renal cell carcinoma line allows expansion of tumor-associated cytotoxic T lymphocytes in the presence of an alloresponse D.J. Schendel B. Frankenberger P. Jantzer S. Cayeux E. Noessner G. Willimsky B. Maget H. Pohla T. Blankenstein 01. Januar 2000 / J Gene Med MLV-10A1 retrovirus pseudotype efficiently transduces primary human CD4+ T lymphocytes M. Gladow C. Becker T. Blankenstein W. Uckert 01. Februar 2000 / Canc Res Interleukin-7/B7.1-encoding adenoviruses induce rejection of transplanted but not nontransplanted tumors G. Willimsky T. Blankenstein 15. April 2015 / Int J Cancer Gene expression profiling of peripheral blood mononuclear cells during treatment with a gene-modified allogeneic tumor cell vaccine in advanced renal cell cancer: tumor-induced immunosuppression and a possible role for NF-κB A. Flörcken M. Grau A. Wolf A. Weilemann J. Kopp B. Dörken T. Blankenstein A. Pezzutto P. Lenz G. Lenz J. Westermann 01. August 2015 / Mol Oncol Potent anti-tumor response by targeting B cell maturation antigen (BCMA) in a mouse model of multiple myeloma F. Oden S.F. Marino J. Brand S. Scheu C. Kriegel D. Olal A. Takvorian J. Westermann B. Yilmaz M. Hinz O. Daumke U.E. Höpken G. Müller M. Lipp Seitennummerierung Aktuelle Seite 1 Seite 2 Nächste Seite Next › Letzte Seite Last »
01. Januar 2000 / Hum Gene Ther Efficient gene transfer into primary human CD8+ T lymphocytes by MuLV-10A1 retrovirus pseudotype W. Uckert C. Becker M. Gladow D. Klein T. Kammertoens L. Pedersen T. Blankenstein
01. Juni 2000 / Immunity CD4+ T cell-mediated tumor rejection involves inhibition of angiogenesis that is dependent on IFNgamma receptor expression by nonhematopoietic cells Z.H. Qin T. Blankenstein
01. Mai 2000 / Bone Marrow Transplant Bcr/abl+ autologous dendritic cells for vaccination in chronic myeloid leukemia J. Westermann J. Kopp I. Koerner G. Richter Z. Qin T. Blankenstein B. Doerken A. Pezzutto
01. Mai 2000 / Bone Marrow Transplant Allogeneic vaccination for renal cell carcinoma: development and monitoring H. Pohla B. Frankenberger B. Stadlbauer R. Oberneder A. Hofstetter G. Willimsky A. Pezzutto B. Doerken T. Blankenstein D.J. Schendel
01. Oktober 2000 / Tissue Antigens Coordinate downregulation of multiple MHC class I antigen processing genes in chemical-induced murine tumor cell lines of distinct origin B. Seliger U. Wollscheid F. Momburg T. Blankenstein C. Huber
01. Dezember 2000 / Gene Ther Expression of B7.1 (CD80) in a renal cell carcinoma line allows expansion of tumor-associated cytotoxic T lymphocytes in the presence of an alloresponse D.J. Schendel B. Frankenberger P. Jantzer S. Cayeux E. Noessner G. Willimsky B. Maget H. Pohla T. Blankenstein
01. Januar 2000 / J Gene Med MLV-10A1 retrovirus pseudotype efficiently transduces primary human CD4+ T lymphocytes M. Gladow C. Becker T. Blankenstein W. Uckert
01. Februar 2000 / Canc Res Interleukin-7/B7.1-encoding adenoviruses induce rejection of transplanted but not nontransplanted tumors G. Willimsky T. Blankenstein
15. April 2015 / Int J Cancer Gene expression profiling of peripheral blood mononuclear cells during treatment with a gene-modified allogeneic tumor cell vaccine in advanced renal cell cancer: tumor-induced immunosuppression and a possible role for NF-κB A. Flörcken M. Grau A. Wolf A. Weilemann J. Kopp B. Dörken T. Blankenstein A. Pezzutto P. Lenz G. Lenz J. Westermann
01. August 2015 / Mol Oncol Potent anti-tumor response by targeting B cell maturation antigen (BCMA) in a mouse model of multiple myeloma F. Oden S.F. Marino J. Brand S. Scheu C. Kriegel D. Olal A. Takvorian J. Westermann B. Yilmaz M. Hinz O. Daumke U.E. Höpken G. Müller M. Lipp